Guardian Therapeutics
PrivateCompany Overview
Guardian Therapeutics is a biotechnology company that discovers and develops aptamer-based therapeutics for hematology, oncology, dermatology, and gastroenterology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guardian Therapeutics Comparables
Compare Guardian Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PentaBind | 82% | |
| TAGCyx Biotechnologies Inc. | 80% | |
| Aptagen, LLC | 78% |
Guardian Therapeutics Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors grew 32% MoM to 674.
Guardian Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Guardian Therapeutics's valuation, stock price, and market status.
Is Guardian Therapeutics a public or private company?
Guardian Therapeutics is a private company.
What is the current stock price of Guardian Therapeutics?
Guardian Therapeutics is a private company with no public stock price. Caplight tracks Guardian Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Guardian Therapeutics worth (valuation)?
Valuation information for Guardian Therapeutics is not publicly available.
Can I buy Guardian Therapeutics stock?
Guardian Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Guardian Therapeutics's last funding round?
Funding round information for Guardian Therapeutics is not publicly available.
Who are the main investors in Guardian Therapeutics?
Investor information for Guardian Therapeutics is not publicly disclosed.
Will Guardian Therapeutics IPO soon?
No public IPO plans have been announced for Guardian Therapeutics.
How can I track Guardian Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Guardian Therapeutics's secondary market activity and sign up for updates.